Sign in or Register

Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of SARS-CoV-2/COVID-19, several of which were validated using virus-infected cell lysates.

Explore the collections of SARS-CoV-2/COVID-19 antibodies >


Fig.1 Glioma

A glioma is a kind of tumor that originates in the spine or brain. It is called a glioma because it arises from glial cells. Gliomas make up about 30% of all brain and central nervous system tumors and about 80% of all malignant brain tumors. Symptoms of gliomas depend on which site of the central nervous system is affected. A brain glioma can cause vomiting, headaches, seizures, and cranial nerve disorders because of enhanced intracranial pressure. A glioma of the optic nerve can damage the eyesight. Spinal cord gliomas may cause weakness, pain or numbness in the extremities. Gliomas do not metastasize by the bloodstream, however they can spread via the cerebrospinal fluid and cause "drop metastases" to the spinal cord. The exact causes of gliomas are remained to be discovered. Some glioma markers like Serum GFAP autoantibody, have been studied recently.